We hope you'll join us for our 4/23 webinar on using data tables to apply reference ranges and AE codes in OC4. For more information and to register, visit https://register.gotowebinar.com/register/2882170018956684555

OpenClinica / Partitions of Multiple Protocols

OpenClinica / Partitions of Multiple Protocols
Hello,
When deploying OpenClinica for multiple independent protocols and different locations, what overlap exists between the studies ?
It seems that these overlaps occur:
§ all CRFs are available across all studies, and that they can be edited by users from a different study
§ all users are visible across all studies
§ all study names (not data) are visible across the platform.
Are there assurances that a Study Director from one study cannot impact another study in the system ?
Is there a good listing of user privileges in the system ?
Thanks.
John McCarthy
Systems Analyst
Scientific Applications and Information Systems
OTIS / NIAID / NIH
[email protected]
Disclaimer: The information in this e-mail and any of its attachments is confidential and may contain sensitive information. It should not be used by anyone who is not the original intended recipient. If you have received this e-mail in error please inform the sender and delete it from your mailbox or any other storage devices. National Institute of Allergy and Infectious Diseases shall not accept liability for any statements made that are sender's own and not expressly made on behalf of the NIAID by one of its representatives.

Comments

  • Paul GalvinPaul Galvin Posts: 886
    OpenClinica / Partitions of Multiple Protocols
    Hi John,

    The overlap is going to occur depending on the role the user has logged in with. If they are a Study Coordinator or a Study Director with Business Administrator privileges, then they will be able to see and edit all of the CRFs, Users, and Studies throughout OpenClinica.

    A Study Coordinator or a Study Director with normal user privileges, will not see the Business Admin module, and therefore not be able to access and edit all of the CRFs, Users, and Studies in OpenClinica. The SC or SD can view all of the CRFs throughout every study, but they would not be able to edit or remove a CRF they did not initially create. The SC or SD would only be able to assign users to their study, but they would not be able to edit any of the user’s global information. Also, the SC or SD can only see studies they have been provided access to, and no other ones throughout the system.

    An SC or SD can not impact any other studies in OpenClinica, unless they are given the permission to access the Study by a Business Administrator or a Technical Administrator.

    Attached is a document that outlines the different Users and Roles within OpenClinica, and I hope it is helpful.

    Paul
    Sent: Friday, June 08, 2007 10:10 AM
    To: [email protected]
    Subject: [Users] OpenClinica / Partitions of Multiple Protocols

    Hello,
    When deploying OpenClinica for multiple independent protocols and different locations, what overlap exists between the studies ?
    It seems that these overlaps occur:
    § all CRFs are available across all studies, and that they can be edited by users from a different study
    § all users are visible across all studies
    § all study names (not data) are visible across the platform.
    Are there assurances that a Study Director from one study cannot impact another study in the system ?
    Is there a good listing of user privileges in the system ?

    Thanks.
    John McCarthy
    Systems Analyst
    Scientific Applications and Information Systems
    OTIS / NIAID / NIH
    [email protected]
    Disclaimer: The information in this e-mail and any of its attachments is confidential and may contain sensitive information. It should not be used by anyone who is not the original intended recipient. If you have received this e-mail in error please inform the sender and delete it from your mailbox or any other storage devices. National Institute of Allergy and Infectious Diseases shall not accept liability for any statements made that are sender's own and not expressly made on behalf of the NIAID by one of its representatives.
    Attachments:
    OpenClinica Users and Roles.doc 166 KB
This discussion has been closed.